In a 69-year-old woman on lisinopril 10 mg daily with a dry cough, what medication should be switched to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switch to an Angiotensin Receptor Blocker (ARB)

In this 69-year-old woman with dry cough on lisinopril 10 mg, you should discontinue the lisinopril immediately and switch to an angiotensin receptor blocker (ARB) such as losartan or valsartan. 1, 2

Why Discontinue Lisinopril

  • ACE inhibitor-induced cough is a well-documented class effect occurring in 5-35% of patients, making it the most common pharmaceutical cause of chronic dry cough 1, 2
  • The cough is not dose-related, so reducing the dose from 10 mg to a lower amount will not help 2, 3
  • Switching to another ACE inhibitor (such as enalapril or ramipril) is futile because all ACE inhibitors cause cough through the same bradykinin-mediated mechanism 2, 4
  • The American College of Chest Physicians gives a Grade B recommendation that discontinuation is the only uniformly effective treatment 1, 2

Risk Factors Present in This Patient

  • Female gender is associated with higher incidence of ACE inhibitor-induced cough compared to males 2
  • This patient's demographic profile increases her likelihood of experiencing this side effect 2

Recommended Replacement: ARBs

  • ARBs (losartan, valsartan, or telmisartan) have a cough incidence comparable to placebo (15-20%) versus 60-69% with ACE inhibitors in patients with prior ACE inhibitor-induced cough 5, 6, 7
  • The American College of Cardiology/American Heart Association provides a Class 1, Level A recommendation (highest level) for using ARBs in patients intolerant to ACE inhibitors due to cough 2
  • Clinical trials demonstrate that valsartan 80 mg produces cough in only 19.5% versus 68.9% with lisinopril, with no significant difference from hydrochlorothiazide placebo 6

Expected Timeline for Cough Resolution

  • After stopping lisinopril, the cough typically resolves within 1-4 weeks, with a median of approximately 26 days (3.5 weeks) 1, 2
  • A minority of patients may require up to 3 months for complete resolution 1, 2
  • If cough persists beyond 4 weeks after discontinuation, evaluate for alternative causes including gastroesophageal reflux disease, heart failure-related pulmonary congestion, or asthma 2

Specific ARB Dosing Recommendations

  • Valsartan: Start at 40-80 mg once daily, can titrate up to 160 mg twice daily for optimal effect 2
  • Losartan: Start at 50 mg once daily, demonstrated in trials to have similar cough incidence to hydrochlorothiazide (17-29%) versus lisinopril (62-69%) 5
  • Allow at least 36 hours between the last lisinopril dose and starting the ARB to minimize adverse effects 2

Monitoring After the Switch

  • Check blood pressure, renal function, and potassium levels within 1-2 weeks after initiating the ARB and after any dose changes 2
  • Monitor for cough resolution over the subsequent 1-4 weeks 1, 2

Critical Pitfalls to Avoid

  • Do not try alternative ACE inhibitors – the cough will recur with any agent in this class 2, 3, 4
  • Do not reduce the lisinopril dose – ACE inhibitor-induced cough is not dose-dependent and persists at any dosage 2, 3
  • Do not assume timing excludes ACE inhibitors – cough can develop within hours or be delayed for months to over a year after starting therapy 1, 2
  • Do not overlook that ACE inhibitors sensitize the cough reflex, potentially amplifying cough from other causes 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.